L-Tyrosine for Cognitive Function

Verdict: Helps cognition only under acute stress

L-tyrosine is not a general brain booster: it only restores working memory and mental flexibility that have been blunted by acute, catecholamine-depleting stressors such as sleep loss, cold, or heavy multitasking, and it does nothing for cognition in rested, unstressed people.

B 🟡 B Preliminary Evidence Published with Warning

🔬Why this grade7-layer evidence engine

This earns a B (Preliminary Evidence), published with a warning, because the human data are real but narrow and weak. Two systematic reviews anchor the case: Jongkees et al. 2015 (PMID 25797188) found tyrosine loading acutely counteracts drops in working memory and information processing under demanding conditions, with no benefit when conditions are easy, and a 2015 rapid evidence assessment (PMID 26126245) reported that every included study showed a positive effect for cognitive stress mitigation, but only enough to support a weak recommendation.

The evidence base is thin and conditional, which caps the grade. Studies are mostly small, acute, single-dose trials, and the response is not uniform: an RCT (PMID 27403851) showed benefits to working memory and inhibitory control depended on DRD2 genotype, while a small anorexia RCT (PMID 29735813, n=19) improved reaction time only in an already depleted clinical group. There is no long-term or large-population data.

Authorities reinforce the caution. EFSA accepts tyrosine as a precursor for catecholamine and dopamine synthesis but specifically rejected 'increased attention' claims, and the UK NHS says it cannot recommend supplementation given inadequate efficacy and safety data. No major clinic (Mayo, Cleveland, Harvard) endorses it for cognition. A drug-interaction warning also applies, notably with MAO inhibitors and levodopa.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.58
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
B · Published with Warning
Confidence
82%
Highly consistent evidence
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
L5 Clinical bodiesAuthoritative stance
0.55
L2 PubMedPrimary literature
0.60
L3 MechanismPlausibility
0.65
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.58
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高階證據未達主導 (0 positive vs 1 negative),由 raw_score 決定
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

Behavioral and cognitive effects of tyrosine intake in healthy human adults (Jongkees et al.)
PMID: 25797188 2015 系統性回顧 n = 15
Finding: Tyrosine loading acutely counteracts decrements in working memory and information processing induced by demanding situational conditions (stress/cognitive load); no clear benefit in non-demanding conditions.
Government
View on PubMed
Tyrosine for Mitigating Stress and Enhancing Performance in Healthy Adult Humans, a Rapid Evidence Assessment
PMID: 26126245 2015 系統性回顧 n = 14
Finding: Weak recommendation in favour of tyrosine for mitigating cognitive stress; all included studies showed a positive effect for cognitive stress mitigation, but insufficient evidence for physical performance.
Government
View on PubMed
Effects of l-Tyrosine on working memory and inhibitory control are determined by DRD2 genotypes: A randomized controlled trial
PMID: 27403851 2016 RCT (double-blind)
Finding: Tyrosine improved working memory and inhibitory control mainly in DRD2 T/T genotype carriers vs C/C homozygotes; effect is genotype-dependent (p-values not in abstract).
View on PubMed
A Double Blind, Randomized Cross-Over Trial of Tyrosine Treatment on Cognitive Function in Severe Hospitalized Anorexia Nervosa Patients
PMID: 29735813 2017 RCT (double-blind) n = 19
Finding: Tyrosine shortened reaction time and memory test duration and improved depressive mood in malnourished anorexia patients (a stressed/depleted clinical population); no adverse effects (p-values not in abstract).
🟠 Limited quality
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
L-Tyrosine — CAS Reg. No. 60-18-4; 21 CFR 172.320; Permitted Technical Effects: FLAVORING AGENT OR ADJUVANT, NUTRIENT SUPPLEMENT; FEMA No. 3736; FEMA GRAS Publication No. 13; JECFA Flavor No. 1434. source↗
L4b EU EFSA
Neutral
The Panel concludes that a cause and effect relationship has been established between the consumption of L-tyrosine in a protein adequate diet and contribution to normal synthesis of catecholamines / dopamine. No evidence has been provided that the protein supply in the diet of the European population is not sufficient to fulfil this function of the amino acid. For increased attention and contr… source↗
L4c UK NHS
Not addressed
unable to provide any recommendations about whether tyrosine supplementation should be introduced into routine clinical practice owing to no appropriate efficacy or safety outcome measures being evaluated source↗
L4d TW TFDA / 衛福部
Neutral
目前得宣稱之保健功效共有13項:護肝、抗疲勞、調節血脂、調節血糖、免疫調節、骨質保健、牙齒保健、延緩衰老、促進鐵吸收、胃腸功能改善、輔助調節血壓、不易形成體脂肪、輔助調整過敏體質。 source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-cognitive-function-INT-l-tyrosine-001 繁體中文版 →